dyax corp (DY8:Frankfurt)

Executive Profile*

Background*

Mr. Gustav A. Christensen has been Chief Executive Officer and President of Dyax Corp. since January 1, 2009. Mr. Christensen serves as Chief Executive Officer and Chairman of the United States Office at affentranger associates sa, Investment arm. Mr. Christensen joined Dyax in April 2007. He has been Chief Executive Officer of Phylos, Inc. since August 2000. He served as Managing Director of Apeiron Partners, LLC, a boutique life sciences investment bank, from 2005 ... to 2007. He served as General Manager of Baxter Travenol Laboratories and served there until 1983. He served as the Vice President of Business Development at Genetics Institute Inc. from 1983 to 1988. He has been Chief Executive Officer or Senior Manager of seven biopharmaceutical firms. He served as Executive Vice President and Chief Business Officer of Dyax Corp. since April 2007. He served as Chief Business Officer of Clavis Pharma ASA until October 2007. He has been Chairman of the Board of Directors at Alpha-Beta Technology since August 1991. He has been Director of Alpha-Beta Technology since December 1990. Mr. Christensen has been a Director of Dyax Corp. since January 1, 2009. He serves as on the Advisory Boards for two venture funds. He served as Director of Diatide, Inc. since 1990. He served as Director of Alantos Pharmaceuticals Holding, Inc. and Cohesive Technologies, Inc. Mr. Christensen received his Master’s of Science degree in Economics from the University of Aarhus (Denmark) and a Master’s degree in Business Administration (MBA) from Harvard Business School.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
DY8:GR	€1.91 EUR	-0.082

COMPETITOR COMPENSATION